top of page

5 High-impact Cancer Vaccine Platforms

This new report focuses on a segment of cancer vaccines companies. It delivers advanced market profiling, interactive mindmaps, information about companies and investors, technology application use cases and other actionable information. 
The current report version reviewed the 5 cancer vaccine platforms: Neoantigen Platform, Tumor-associated Antigens Platform, Cellular Platform, and Oncolytic Viruses Platform — and the latest breakthrough and a potentially disruptive research strategy —  Antigenic Essence Platform, which are actively developing their products to enter the market of immunotherapy. As a result we conducted assessment of more than 245 investors, 150 companies and R&D centers, and detailed analysis of more than 30 of them.

Full Report 
75 Pages
5 High-impact Cancer Vaccine Platforms (4).png
One Pager
One Pager .png
25 Pages
Teaser (4).png
Cancer Vaccines and 
Cell Immunotherapies 
by Delivery Form  
5 High-impact Cancer Vaccine Platforms (7).png
Cancer Vaccines 
by Antigen 

5 High-impact Cancer Vaccine Platforms (5).png
bottom of page